Learn what collagen is, why it may or may not have benefits for psoriasis, according to experts, and what the research has found so far.

A real world systematic review and meta-analysis found tildrakizumab improved plaque psoriasis severity and quality of life ...

In both trials, envudeucitinib showed greater skin clearance than placebo on both co-primary endpoints at week 16.

Alumis (ALMS) stock is soaring after the company announced positive trial results for its plaque psoriasis drug ...

Psoriasis is a chronic, recurrent, and incurable autoimmune disease in which the body mistakenly attacks its own tissue, ...

Alumis (ALMS) stock surged after two Phase 3 trial for its lead drug, envudeucitinib, succeeded against plaque psoriasis.